Sundial Growers Finally Closes Purchase Of Alcanna

Sundial Growers (NASDAQ: SNDL) has finally closed on its much-delayed purchase of retailer Alcanna Inc (TSX: CLIQ). The transaction saw the cannabis firm pay a total of $320 million in cash and shares to acquire the retailer.

The transaction is rather significant for Sundial, given Alcanna’s role as one of the largest alcohol retailers in the country, and one of the largest in North America. The company also owns a majority stake in Nova Cannabis, a Canadian cannabis retailer, whom is a competitor of Sundials current retail cannabis operations.

Alcanna currently operates 171 retail locations, which are predominantly found in Alberta, while Nova Cannabis operates 78 retail cannabis operations. Collectively, the company generated positive cash flow from operating activities in 2021 of $18.3 million. More importantly, Sundial now owns or operates over 180 cannabis retail locations in Canada, which appears to be one of the primary motives behind the transaction.

The transaction itself saw shareholders of Alcanna receive 8.85 Sundial shares for each Alcanna share held, as well as $1.50 in cash. Alcanna shareholders on a combined basis own a 13.4% stake in Sundial on a post-transaction basis. Alcanna shares are expected to cease trading on April 4 as a result of the transaction.

Separately, Nova Cannabis (TSX: NOVC) this morning announced that it had seen major management changes as a result of the acquisition of its majority holder by Sundial. James Burn, Thomas Bitove, Ross Sinclair, Marvin Singer and Darren Karasiuk all resigned from the board of directors, while Karasiuk also resigned as President and CEO.

Current COO, Marcie Kiziak, as a result was named as the new CEO of the company as well as named as the President of Cannabis Retail at Sundial. The new board now consists of Sundial CEO Zach George as Chair, along with Anne Fitzgerald, Marcia Kiziak, Christopher Pelyk, Jeffrey Dean, and Share Mogk-Edwards, as well as Ron Hozjan, the only prior member to remain on the board.

The company has also sold all 21 of its Ontario retail cannabis locations, due to regulations in the province related to producers owning retailers. Instead, the retailers will operate under a brand licensing and services agreement, while Nova will hold a re-purchase option on them as well. The locations were sold to Spirit Leaf Ontario, for a total of $11.0 million.

Sundial Growers last traded at $0.72 on the Nasdaq.


Information for this briefing was found via Edgar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

The Gold Trade Is Shifting From Margins to Growth | Geordie Mark – Blue Jay Gold

CopAur Minerals – This PEA Has A Mine Life of What?!

Ontario’s Fast Track to Silver Production Is Starting to Matter | Frank Basa – Nord Precious Metals

Recommended

Questcorp Kicks Off Fully Funded Phase 2 Drilling at La Union

Cambria Gold Hits 483 g/t Gold in First Underground Infill Results at Premier

Related News

Aurora Cannabis Dumps 23% Stake In Alcanna At 80% Loss

Aurora Cannabis (TSX: ACB) (NYSE: ACB) continues to liquidate its assets as it tries to...

Wednesday, June 3, 2020, 08:46:41 AM

Sundial Growers Partners With Choklat To Enter Edibles Market

Sundial Growers (NASDAQ: SNDL) has entered the edibles market. The company this morning announced that...

Monday, November 9, 2020, 09:01:09 AM

Sundial Growers Forms Investment Joint Venture, Commits Initial $100 Million To Project

Sundial Growers (NASDAQ: SNDL) this morning announced that it has entered into a joint venture...

Monday, March 15, 2021, 08:09:01 AM

Canaccord Lifts Sundial Growers Price Target To $0.80 Following Alcanna Transaction News

On October 7, Sundial Growers (NASDAQ: SNDL) announced that they entered into an agreement to...

Wednesday, October 13, 2021, 11:46:00 AM

Canaccord Raises Sundial’s Price Target To $0.40, Casts Doubt On Zenabis

After a very busy and dilutive December, where shares outstanding went from 485.5 million to...

Monday, January 4, 2021, 11:11:00 AM